Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treatment of Steroid Refractory Gastro-intestinal Acute Graft-versus-Host disEase afteR AllogeneiC Hematopoietic Stem celL Transplantation With fEcal Microbiota tranSfer

Next Previous
Trial Profile

Treatment of Steroid Refractory Gastro-intestinal Acute Graft-versus-Host disEase afteR AllogeneiC Hematopoietic Stem celL Transplantation With fEcal Microbiota tranSfer

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 31 Jul 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Maa-T-013 (Primary)
  • Indications Graft-versus-host disease
  • Focus Proof of concept; Therapeutic Use
  • Acronyms HERACLES
  • Sponsors MaaT Pharma

Most Recent Events

  • 26 Jul 2023 Results presented in a MaaT Pharma Media Release.
  • 26 Jul 2023 According to a MaaT Pharma media release, pooled data from this study(n=24) and Expanded Access Program (n=52), in France published in the eClinicalMedicine.
  • 17 Mar 2022 According to a MaaT Pharma media release, positive results from this study and its compassionate use program (EAP, n=52) will be reported in an oral presentation at the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT 2022).

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top